In summary, our study identified HADHB as a key regulatory factor for 5FU sensitivity in CRC, possibly through the HADHB-DUOX2-ROS signaling pathway, in which lipid metabolism may also be involved. The gene discussed is DUOX2; the disease is colorectal carcinoma.